FdaApplication

ANDA 214549

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTEVA PHARMACEUTICALS USA INC
application_typeANDA
approval_date2021-02-11

Products (2)

ProductActive ingredientStrengthDosage form
ERYTHROMYCINERYTHROMYCIN250MGTABLET;ORAL
ERYTHROMYCINERYTHROMYCIN500MGTABLET;ORAL

2 products